サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571923

動脈ステントの世界市場

Arterial Stents

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
動脈ステントの世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動脈ステントの世界市場は2030年までに252億米ドルに達する見込み

2023年に145億米ドルと推定される動脈ステントの世界市場は、分析期間2023-2030年にCAGR 8.2%で成長し、2030年には252億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである冠動脈ステントは、CAGR 8.1%を記録し、分析期間終了時には128億米ドルに達すると予測されます。末梢ステントセグメントの成長率は、分析期間でCAGR 8.4%と推定されます。

米国市場は推定38億米ドル、中国はCAGR12.0％で成長予測

米国の動脈ステント市場は2023年に38億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに63億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは12.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と7.4%と予測されています。欧州では、ドイツがCAGR 5.0%で成長すると予測されています。

世界の動脈ステント市場- 主要動向と促進要因のまとめ

なぜ動脈ステントが心血管疾患の管理に不可欠なのか？

動脈ステントは、心血管疾患、特に冠動脈疾患（CAD）や末梢動脈疾患（PAD）を患う患者の治療に欠かせない医療機器となっています。これらの小さなチューブのような器具は、閉塞したり狭くなったりした動脈を開き、心臓や他の重要な臓器への適切な血流を確保するために使用されます。心血管系疾患は依然として世界の死因の上位を占めており、動脈ステントは心臓発作、脳卒中、四肢虚血などの合併症を軽減する上で重要な役割を担っています。肥満、糖尿病、高血圧などのライフスタイルに関連した健康状態の増加により、動脈ステントの需要はさらに高まり、現代の心臓血管治療の重要な要素となっています。

技術の進歩は動脈ステントのデザインにどのような革命をもたらしているか？

薬剤溶出ステント（DES）と生体吸収性ステントの開拓は動脈ステント市場における重要な技術的進歩です。薬剤溶出ステントは時間の経過とともに薬剤を放出し、動脈の再狭窄を予防します。目的を果たすと徐々に溶解する生体吸収性ステントは、従来の金属製ステントに伴う長期的な合併症を軽減する有望なソリューションです。さらに、光干渉断層計（OCT）や血管内超音波（IVUS）などの画像技術の進歩により、ステント留置の精度が向上し、ステント留置術の成功率が高まっています。これらの技術革新は、複雑な心血管系疾患を管理するための、より安全で効果的なソリューションを提供することで、ステント市場に変革をもたらしつつあります。

どのような規制基準が動脈ステント市場を形成しているか？

規制基準は、動脈ステント市場において重要な役割を果たしています。なぜなら、これらの医療機器の安全性と有効性は、患者に使用される前に慎重に評価されなければならないからです。FDAや欧州医薬品庁（EMA）などの機関は、ステントが厳しい品質・安全基準を満たしていることを確認するために、厳格な臨床試験を受けることを義務付けています。これには、ステントが血液凝固や炎症などの副作用を起こすことなく動脈開存性を維持する能力を実証することも含まれます。また、市販後調査も不可欠であり、これによって規制機関は長期的な患者の転帰を監視し、新しいステント技術に関連する新たなリスクを特定することができます。これらの基準を遵守することは、メーカーが承認を得てヘルスケアプロバイダーや患者との信頼を築くために不可欠です。

動脈ステント市場の成長を促進する要因は？

動脈ステント市場の成長は、心血管疾患の有病率の上昇、ステント設計の技術的進歩、低侵襲手術の需要の増加など、いくつかの要因によってもたらされます。心臓病と脳卒中の世界の負担は、特にヘルスケアシステムが予防医療と早期診断にシフトするにつれて、ステントベースの介入に対する需要の拡大を促しています。薬剤溶出性ステントや生体吸収性ステントなどの技術革新が患者の予後を改善し、先進国市場でも新興国市場でも採用が増加しています。回復が早く合併症が少ない低侵襲手術への嗜好の高まりが、動脈ステントの使用をさらに後押ししています。また、新興諸国におけるヘルスケアインフラの拡充により、高度な心血管治療へのアクセスが増加し、市場成長の新たな機会が生まれています。

調査対象企業の例（全46件）

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Group, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Stentys SA
  • Terumo Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16154

Global Arterial Stents Market to Reach US$25.2 Billion by 2030

The global market for Arterial Stents estimated at US$14.5 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.8 Billion by the end of the analysis period. Growth in the Peripheral Stents segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 12.0% CAGR

The Arterial Stents market in the U.S. is estimated at US$3.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 12.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Arterial Stents Market - Key Trends & Drivers Summarized

Why Are Arterial Stents Crucial for Managing Cardiovascular Diseases?

Arterial stents have become an essential medical device in the treatment of cardiovascular diseases, particularly in patients suffering from coronary artery disease (CAD) or peripheral artery disease (PAD). These small, tube-like devices are used to open up blocked or narrowed arteries, ensuring proper blood flow to the heart and other critical organs. With cardiovascular diseases remaining the leading cause of death worldwide, arterial stents play a vital role in reducing complications such as heart attacks, strokes, and limb ischemia. The growing incidence of lifestyle-related health conditions, including obesity, diabetes, and hypertension, has further driven the demand for arterial stents, making them a key component of modern cardiovascular care.

How Are Technological Advances Revolutionizing Arterial Stent Design?

The development of drug-eluting stents (DES) and bioresorbable stents represents a significant technological advancement in the arterial stent market. Drug-eluting stents release medications over time to prevent restenosis, the re-narrowing of the artery, which has improved patient outcomes by reducing the need for repeat interventions. Bioresorbable stents, which gradually dissolve after fulfilling their purpose, offer a promising solution for reducing long-term complications associated with traditional metal stents. Furthermore, advances in imaging technology, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), have improved the precision with which stents are deployed, enhancing the success of stenting procedures. These innovations are transforming the stent market by offering safer, more effective solutions for managing complex cardiovascular conditions.

What Regulatory Standards Are Shaping the Arterial Stents Market?

Regulatory standards play a crucial role in the arterial stents market, as the safety and efficacy of these medical devices must be carefully evaluated before they can be used in patients. Agencies such as the FDA and European Medicines Agency (EMA) require that stents undergo rigorous clinical testing to ensure they meet stringent quality and safety standards. This includes demonstrating the stent's ability to maintain arterial patency without causing adverse effects such as blood clotting or inflammation. Post-market surveillance is also essential, as it allows regulatory bodies to monitor long-term patient outcomes and identify any emerging risks associated with new stent technologies. Compliance with these standards is vital for manufacturers to gain approval and build trust with healthcare providers and patients.

What Factors Are Driving the Growth of the Arterial Stents Market?

The growth in the arterial stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and the increasing demand for minimally invasive procedures. The global burden of heart disease and stroke is prompting greater demand for stent-based interventions, particularly as healthcare systems shift toward preventive care and early diagnosis. Technological innovations such as drug-eluting and bioresorbable stents are improving patient outcomes, leading to increased adoption in both developed and emerging markets. The growing preference for minimally invasive procedures, which offer quicker recovery times and reduced complications, is further boosting the use of arterial stents. Additionally, the expansion of healthcare infrastructure in developing countries is opening new opportunities for market growth as access to advanced cardiovascular care increases.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Group, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Stentys SA
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Arterial Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Driving Demand for Arterial Stents
    • Technological Advancements in Stent Design Enhancing Market Growth
    • Rising Adoption of Minimally Invasive Procedures Boosting Stent Utilization
    • Expansion of Aging Population Contributing to Growth in Arterial Stent Market
    • Development of Biodegradable Stents Creating New Opportunities for Market Expansion
    • Growing Use of Drug-Eluting Stents for Long-Term Efficacy Driving Demand
    • Increased Healthcare Spending in Emerging Economies Fuelling Market Growth
    • Rising Focus on Early Detection and Treatment of Arterial Blockages Boosting Adoption
    • Expansion in Clinical Trials and R&D Activities Supporting Technological Innovation
    • Government Initiatives Aimed at Improving Cardiovascular Care Increasing Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Arterial Stents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Arterial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Coronary Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Coronary Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Carotid Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Carotid Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Carotid Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Iliac Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Iliac Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Iliac Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arterial Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arterial Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arterial Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arterial Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION